Literature DB >> 835925

Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation.

A B Schneider, M J Favus, M E Stachura, J E Arnold, U Y Ryo, S Pinsky, M Colman, M J Arnold, L A Frohman.   

Abstract

The level of thyroglobulin in plasma was measured in 904 subjects with a history of head and neck irradiation during childhood to evaluate its potential value in screening for and differentiating thyroid neoplasms. Mean plasma thyroglobulin level was significantly elevated in subjects with nodular thyroid disease versus those without evidence of nodules (49.8 versus 27.0 ng/ml). However, the overlap with normal subjects does not allow thyroglobulin assays to serve as the only screening procedure. The mean levels in subjects with benign and malignant thyroid nodules were indistinguishable (48.8 versus 53.9 ng/ml). Thirteen percent of otherwise normal-appearing subjects had elevated values that may represent clinically inapparent thyroid disease. It is concluded that in screening large numbers of persons at risk for thyroid neoplasia, thyroglobulin assays are useful in combination with other modes of evaluation. The assay is without value in distinguishing benign from malignant disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835925     DOI: 10.7326/0003-4819-86-1-29

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  The value of serum thyroglobulin measurement as a marker of cancer recurrence in the follow-up of patients previously treated for differentiated thyroid tumor.

Authors:  E Roti; G Robuschi; R Emanuele; P Bandini; A Russo; P Riva; E Galassi; U P Guerra; A Manfredi; A Bozzetti; A M Guazzi; A Gnudi
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

2.  Methods of investigation in the diagnosis and management of thyroid carcinoma.

Authors:  M N Maisey
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

3.  Comparison of serum thyroglobulin with iodine scans in thyroid cancer.

Authors:  M A Charles
Journal:  J Endocrinol Invest       Date:  1982 Jul-Aug       Impact factor: 4.256

Review 4.  [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)].

Authors:  H Schatz; S Grebe; E Mäser; J Teuber; W Horn; O Schröder; C Schatz
Journal:  Klin Wochenschr       Date:  1982-05-03

5.  Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Authors:  C B Webb; M L Vance; M O Thorner; G Perisutti; J Thominet; J Rivier; W Vale; L A Frohman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

6.  Thyroid iodine content and serum thyroglobulin level following external irradiation to the neck for Hodgkin's disease.

Authors:  M Schlumberger; M Sebagh; F De Vathaire; C Bayle; P Fragu; C Parmentier
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

7.  Serum thyroglobulin in thyroid carcinoma and other thyroid disorders.

Authors:  F Pacini; A Pinchera; C Giani; L Grasso; F Doveri; L Baschieri
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

8.  Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation.

Authors:  S C Ng Tang Fui; R Hoffenberg; M N Maisey; E G Black
Journal:  Br Med J       Date:  1979-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.